Improving outcomes through collaboration

Diane M. Thiboutot, Julie C. Harper, Katharine O'Connell, Phoebe Rich, Steven J. Sondheimer

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A roundtable was convened to examine the issues surrounding the use of hormonal therapy in the treatment of acne. Obstetrician-gynecologists (OB/GYNs) and dermatologists often have varying views with regard to the use of oral contraceptives (OCs) and other agents in patients with acne. If polycystic ovary syndrome (PCOS), the most common hormonal cause of acne, has been diagnosed, the use of OCs is not usually disputed. Hormonal evaluation is recommended for certain conditions such as virilization. Although PCOS is often the source of the problem, it is important to rule out a testosterone-producing tumor or an adrenal tumor. It was determined, however, that the perception that OCs cause cervical and breast cancer persists among some dermatologists. Even in women with a family history of breast cancer, OCs do not increase the risk. Nor is cervical cancer related to OC use; rather, it results from human papillomavirus. Thus, patients should be assured that OCs will not increase their risk for either of these cancers. Female patients should be advised to see their gynecologists annually for breast and pelvic examinations and to discuss their concerns surrounding the use of OCs.

Original languageEnglish (US)
Pages (from-to)26-31
Number of pages6
JournalCutis
Volume81
Issue number1 SUPPL.
StatePublished - Jan 1 2008

Fingerprint

Oral Contraceptives
Acne Vulgaris
Polycystic Ovary Syndrome
Uterine Cervical Neoplasms
Breast Neoplasms
Virilism
Gynecological Examination
Glandular and Epithelial Neoplasms
Mouth Neoplasms
Contraceptive Agents
Testosterone
Neoplasms
Breast
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

Thiboutot, D. M., Harper, J. C., O'Connell, K., Rich, P., & Sondheimer, S. J. (2008). Improving outcomes through collaboration. Cutis, 81(1 SUPPL.), 26-31.

Improving outcomes through collaboration. / Thiboutot, Diane M.; Harper, Julie C.; O'Connell, Katharine; Rich, Phoebe; Sondheimer, Steven J.

In: Cutis, Vol. 81, No. 1 SUPPL., 01.01.2008, p. 26-31.

Research output: Contribution to journalArticle

Thiboutot, DM, Harper, JC, O'Connell, K, Rich, P & Sondheimer, SJ 2008, 'Improving outcomes through collaboration', Cutis, vol. 81, no. 1 SUPPL., pp. 26-31.
Thiboutot DM, Harper JC, O'Connell K, Rich P, Sondheimer SJ. Improving outcomes through collaboration. Cutis. 2008 Jan 1;81(1 SUPPL.):26-31.
Thiboutot, Diane M. ; Harper, Julie C. ; O'Connell, Katharine ; Rich, Phoebe ; Sondheimer, Steven J. / Improving outcomes through collaboration. In: Cutis. 2008 ; Vol. 81, No. 1 SUPPL. pp. 26-31.
@article{760a4739fa0c41c4b1e8e44260fa283d,
title = "Improving outcomes through collaboration",
abstract = "A roundtable was convened to examine the issues surrounding the use of hormonal therapy in the treatment of acne. Obstetrician-gynecologists (OB/GYNs) and dermatologists often have varying views with regard to the use of oral contraceptives (OCs) and other agents in patients with acne. If polycystic ovary syndrome (PCOS), the most common hormonal cause of acne, has been diagnosed, the use of OCs is not usually disputed. Hormonal evaluation is recommended for certain conditions such as virilization. Although PCOS is often the source of the problem, it is important to rule out a testosterone-producing tumor or an adrenal tumor. It was determined, however, that the perception that OCs cause cervical and breast cancer persists among some dermatologists. Even in women with a family history of breast cancer, OCs do not increase the risk. Nor is cervical cancer related to OC use; rather, it results from human papillomavirus. Thus, patients should be assured that OCs will not increase their risk for either of these cancers. Female patients should be advised to see their gynecologists annually for breast and pelvic examinations and to discuss their concerns surrounding the use of OCs.",
author = "Thiboutot, {Diane M.} and Harper, {Julie C.} and Katharine O'Connell and Phoebe Rich and Sondheimer, {Steven J.}",
year = "2008",
month = "1",
day = "1",
language = "English (US)",
volume = "81",
pages = "26--31",
journal = "Cutis",
issn = "0011-4162",
publisher = "Quadrant Healthcom Inc.",
number = "1 SUPPL.",

}

TY - JOUR

T1 - Improving outcomes through collaboration

AU - Thiboutot, Diane M.

AU - Harper, Julie C.

AU - O'Connell, Katharine

AU - Rich, Phoebe

AU - Sondheimer, Steven J.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - A roundtable was convened to examine the issues surrounding the use of hormonal therapy in the treatment of acne. Obstetrician-gynecologists (OB/GYNs) and dermatologists often have varying views with regard to the use of oral contraceptives (OCs) and other agents in patients with acne. If polycystic ovary syndrome (PCOS), the most common hormonal cause of acne, has been diagnosed, the use of OCs is not usually disputed. Hormonal evaluation is recommended for certain conditions such as virilization. Although PCOS is often the source of the problem, it is important to rule out a testosterone-producing tumor or an adrenal tumor. It was determined, however, that the perception that OCs cause cervical and breast cancer persists among some dermatologists. Even in women with a family history of breast cancer, OCs do not increase the risk. Nor is cervical cancer related to OC use; rather, it results from human papillomavirus. Thus, patients should be assured that OCs will not increase their risk for either of these cancers. Female patients should be advised to see their gynecologists annually for breast and pelvic examinations and to discuss their concerns surrounding the use of OCs.

AB - A roundtable was convened to examine the issues surrounding the use of hormonal therapy in the treatment of acne. Obstetrician-gynecologists (OB/GYNs) and dermatologists often have varying views with regard to the use of oral contraceptives (OCs) and other agents in patients with acne. If polycystic ovary syndrome (PCOS), the most common hormonal cause of acne, has been diagnosed, the use of OCs is not usually disputed. Hormonal evaluation is recommended for certain conditions such as virilization. Although PCOS is often the source of the problem, it is important to rule out a testosterone-producing tumor or an adrenal tumor. It was determined, however, that the perception that OCs cause cervical and breast cancer persists among some dermatologists. Even in women with a family history of breast cancer, OCs do not increase the risk. Nor is cervical cancer related to OC use; rather, it results from human papillomavirus. Thus, patients should be assured that OCs will not increase their risk for either of these cancers. Female patients should be advised to see their gynecologists annually for breast and pelvic examinations and to discuss their concerns surrounding the use of OCs.

UR - http://www.scopus.com/inward/record.url?scp=39049166210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39049166210&partnerID=8YFLogxK

M3 - Article

C2 - 18340677

AN - SCOPUS:39049166210

VL - 81

SP - 26

EP - 31

JO - Cutis

JF - Cutis

SN - 0011-4162

IS - 1 SUPPL.

ER -